The Technical Analyst
Direxion Daily S&P [LABD]
Exchange: NYSE
Direxion Daily S&P Price, Forecast, Insider, Ratings, Fundamentals & Signals
4.53% $8.53
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 103.89 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 12.18 mill |
| Avg Daily Volume: | 16.03 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 23.85 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 7.90 - 9.16 ( +/- 7.41%) |
| ATR Model: 14 days |
Forecast:
16:00 - $8.56
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $8.56
Forecast 2: 16:00 - $8.56
Forecast 3: 16:00 - $8.56
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $8.53 (4.53% ) |
| Volume | 13.58 mill |
| Avg. Vol. | 16.03 mill |
| % of Avg. Vol | 84.74 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For LABD
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
LABD
The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Last 10 Buy Signals
| Date | Signal | @ |
|---|---|---|
| XLMUSD | May 8 - 23:19 | $0.107 |
| WOOUSD | May 8 - 23:18 | $0.286 |
| OSMOUSD | May 8 - 23:18 | 0.859 |
| QTUMUSD | May 8 - 23:18 | $3.54 |
| NXMUSD | May 8 - 23:15 | 65.40 |
| FLUXUSD | May 8 - 23:19 | $0.892 |
| APE18876USD | May 8 - 23:18 | 1.230 |
| ANKRETHUSD | May 8 - 23:18 | 3 446.83 |
| CFXUSD | May 8 - 23:18 | $0.212 |
| DCRUSD | May 8 - 23:18 | $20.25 |
Latest News
2024-05-01 13:00:45 - Zacks Investment Research
5 Inverse ETFs That Gained More Than 20% in April
The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market's worst month of 2024. This has resulted in huge gains for inverse or inverse-leveraged ETFs.
2024-04-23 15:36:53 - ETF Trends
Top Performing Leveraged/Inverse ETFs: 04/21/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2024-04-23 09:00:23 - Zacks Investment Research
5 Best Inverse-Leveraged ETFs of Last Week
Last week witnessed the largest collective loss for the "Magnificent Seven" technology-related stocks, with a total of $950 billion erased from their market capitalizations.
2024-04-09 13:11:19 - ETF Trends
Top Performing Leveraged/Inverse ETFs: 04/07/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2024-03-19 15:08:01 - ETF Trends
Top Performing Leveraged/Inverse ETFs: 03/17/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2024-03-18 09:00:27 - Zacks Investment Research
Best Inverse/Leveraged ETFs of Last Week
2024-01-26 08:28:39 - ETF Trends
Early IPO Activity Could Spell Bullishness for Biotech Industry
Since the end of October 2023, the S&P 500 Biotechnology Select Industry Index jumped over 30%. It could maintain its upward trajectory given the early IPO activity in 2024 thus far.
2024-01-05 17:56:37 - Seeking Alpha
LABD: An Absolute Avoid
Shorting and inverse bets don't work over time on average, making inverse funds like Direxion Daily S&P Biotech Bear 3X Shares ETF a big avoid. The LABD ETF is a triple-leveraged inverse ETF that focuses on the biotechnology sector and aims to profit from a decline in the value of the index it tracks. LABD is not suitable for long-term investment, incurs high costs, and experiences high volatility, making it a high-risk, high-reward investment.
2023-11-14 15:53:59 - ETF Trends
Top Performing Leveraged/Inverse ETFs: 11/12/2023
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2023-11-13 09:02:07 - Zacks Investment Research
Best Inverse/Leveraged ETFs of Last Week
